Literature DB >> 2968884

Microalbuminuria in diabetes: relationships between urinary albumin excretion and diabetes-related variables.

W Gatling1, M A Mullee, C Knight, R D Hill.   

Abstract

A single observer reviewed 842 of the 917 known diabetic patients registered with 40 GPs in the Poole area. Fifty-nine per cent (493) of those reviewed submitted a timed overnight urine collection to measure albumin excretion rate (AER) and overnight albumin/creatinine ratio (ON-Alb/Creat); 43 samples were excluded because of urinary tract infection and/or proteinuria. A random urine sample was obtained in 607 diabetic patients to measure the random albumin/creatinine ratio (R-Alb/Creat); 68 specimens were excluded because of infection and/or proteinuria, and in a further 10 samples urinary creatinine was not measured. Stepwise multiple regression analyses found significant associations with the following variables: for AER, blood glucose (p = 0.001), smoking category (p = 0.002), sex (p = 0.034), and systolic blood pressure (p = 0.035); for R-Alb/Creat, blood glucose (p = 0.001), retinopathy (p = 0.004), systolic blood pressure (p = 0.004), diastolic blood pressure (p = 0.015), coronary artery disease (p = 0.02), sex (p = 0.034), and vibration sense (p = 0.038). Interestingly, glycosylated haemoglobin was not a significant determinant of albuminuria in either analysis.

Entities:  

Mesh:

Year:  1988        PMID: 2968884     DOI: 10.1111/j.1464-5491.1988.tb01003.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

1.  Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians.

Authors:  R G Nelson; C L Kunzelman; D J Pettitt; M F Saad; P H Bennett; W C Knowler
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

2.  UK Prospective Diabetes Study (UKPDS). IX: Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy.

Authors: 
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

3.  A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients.

Authors:  G Joner; O Brinchmann-Hansen; C G Torres; K F Hanssen
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

4.  Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study.

Authors:  R Mangili; G Deferrari; U Di Mario; O Giampietro; R Navalesi; R Nosadini; G Rigamonti; R Spezia; G Crepaldi
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

5.  Microalbuminuria in non-insulin-dependent (type 2) Nigerian diabetics: relation to glycaemic control, blood pressure and retinopathy.

Authors:  R T Erasmus; G Oyeyinka; A Arije
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

6.  UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia.

Authors: 
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

7.  Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark.

Authors:  N de F Olivarius; A H Andreasen; N Keiding; C E Mogensen
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

8.  Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area.

Authors:  E Standl; H Stiegler
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

9.  Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study.

Authors:  S M Haffner; C Gonzales; R A Valdez; L Mykkänen; H P Hazuda; B D Mitchell; A Monterrosa; M P Stern
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.